Skip to main content
Peter Bitterman, MD, Pulmonology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

PeterBruceBittermanMD

Pulmonology • Minneapolis, MN

Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease

Professor, Medicine, University of Minnesota Medical School

Join to view full profile

Dr. Bitterman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bitterman's full profile

Already have an account?

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1978 - 1985
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1976 - 1978
  • Yale School of Medicine
    Yale School of MedicineClass of 1976

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1977 - Present
  • MN State Medical License
    MN State Medical License 1985 - 2021

Awards, Honors, & Recognition

  • Elected Member Association of American Physicians, 2000
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 1994

Publications & Presentations

PubMed

Grant Support

  • ROLE OF FIBROTIC EXTRACELLULAR MATRIX IN GENERATING THE IPF FIBROBLASTNIH/NHLBI2014–2018
  • Translational Control Of The Fibroblast Phenotype In IPFNational Heart, Lung, And Blood Institute2009–2012
  • Translational Control In IPFNational Heart, Lung, And Blood Institute2008–2011
  • Translational State Assay For Human SamplesNational Center For Research Resources2008–2010
  • Antifibrotic Drug Discovery In Acute Lung InjuryNational Heart, Lung, And Blood Institute2004–2007
  • Molecular Targets For Drug Discovery In IPFNational Heart, Lung, And Blood Institute2003–2006
  • SCOR In Acute Lung InjuryNational Heart, Lung, And Blood Institute1994–2003
  • Translational Repressors As Therapy For OBNational Institute Of Allergy And Infectious Diseases2001–2002
  • Translational Control Of Fibroblast ViabilityNational Heart, Lung, And Blood Institute1999–2002
  • Training In Lung ScienceNational Heart, Lung, And Blood Institute1999–2002
  • Transgenic Murine Model Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute1996–1999
  • Role Of Apoptosis In Lung RepairNational Heart, Lung, And Blood Institute1996–1998
  • Training-Pulmonary Cell &Molecular Biology &PhysiologyNational Heart, Lung, And Blood Institute1994–1998
  • Mesenchymal Cell Subpopulations In Acute Lung FibrosisNational Heart, Lung, And Blood Institute1987–1991

Hospital Affiliations

Dr. Peter Bitterman, Dr. Peter Bitterman, MD, Dr. P Bitterman, Dr. Peter Bruce Bitterman